The Use of Biosimilars in Hospital and Pharmacy Is Doubled by 4.9 Million Packs and 2.7 Million Packs Respectively.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The use of biosimilar medicines has experienced a "significant expansion" throughout the National Health System. This is highlighted by the Ministry of Health, which has published the report 'Adoption of generic, hybrid and biosimilar medicines in the National Health System', a study from the period 2020-2025 that positions these drugs as "key parts" for the sustainability of the public system. The volume of biosimilars in hospitals increased fr…
The Ministry of Health has published the report 'Adoption of generic, hybrid and biosimilar medicines in the National Health System (NSS)', which shows that the use of biosimilars in hospitals and pharmacies has doubled in a five-year period, since this was in 2025 of 4.9 million and 2.7 million containers, respectively, by 2.4 million and 1.3 million in 2020.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
